CritiTech Particle Engineering Solutions (CT PES) is a rapidly-growing, multi-service, pharmaceutical Contract Development Manufacturing Organization (CDMO) and Contract Research Organization (CRO) with extensive experience and expertise in particle engineering, material characterization, analytical testing, early-stage drug development, and pre-clinical and clinical manufacturing. CritiTech Particle Engineering Solutions uses two primary technologies to help its customers engineer, formulate and manufacture their drugs – Spray Drying and Supercritical Precipitation. CritiTech Particle Engineering Solutions provides a suite of CDMO services, helping its customers develop new drugs and improved next generation particles from proof-of-concept through Phase III cGMP clinical production.